Skip to main content

Table 2 Means ± s.e. for each variable calculated in the two groups of patients at baseline, and at 3, 6, and 12 months of treatments (n = 40 + 40 matched)

From: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma

 

Group A

(means ± s.e.)

Group B

(means ± s.e.)

 

T0

T3

T6

T12

T0

T3

T6

T12

FEV1% pred.

82.40

± 1.69

87.08

± 1.58

89.98

± 2.0

91.88

± 2.13

81.93

± 2.0

89.50

± 2.64

90.9

± 3.23

99.1

± 3.24

Exac. Rate/p

0.63

± 0.13

0.53

± 0.12

0.58

± 0.13

0.60

± 0.18

1.05

± 0.16

0.28

± 0.07

0.33

± 0.08

0.18

± 0.08

Hosp. rate/p.

0.25

± 0.07

0.15

±0.06

0.08

± 0.04

0.13

± 0.05

0.30

± 0.07

0.08

± 0.04

0.10

± 0.05

0.03

± 0.03

H. duration (days)

0.83

± 0.26

0.28

± 0.12

0.48

± 0.38

0.60

± 0.31

0.88

± 0.31

0.08

± 0.04

0.10

± 0.05

0.03

± 0.03

Inactivity

(days)/p

2.88

± 0.63

1.53

± 0.27

1.10

± 0.21

1.45

± 0.58

3.35

± 0.63

0.60

± 0.19

1.35

± 0.34

0.83

± 0.39

Spec. Visits/p

0.68

± 0.13

0.68

± 0.11

0.65

± 0.08

1.05

± 0.13

0.70

± 0.16

0.28

± 0.07

0.35

± 0.08

0.23

± 0.08

GP visits/p

1.33

± 0.23

0.85

± 0.15

0.55

± 0.13

0.63

± 0.15

1.53

± 0.24

0.38

± 0.12

0.78

± 0.12

0.25

± 0.09

Courses of steroids/p

0.90

± 0.15

0.73

0.13

0.48

± 0.11

0.30

± 0.09

1.08

± 0.16

0.33

0.08

0.30

± 0.08

0.13

± 0.06

Courses of antibiotics/p.

0.85

± 0.16

0.63

0.10

0.43

± 0.12

0.40

± 0.11

1.03

± 0.13

0.35

0.08

0.33

± 0.08

0.15

± 0.08

  1. Group A: Beclomethasone dipropionate/Formoterol (BDP/F) 100/6 μg b.i.d., via Nexthaler. Group B: Fluticasone furoate/Vilanterol (FF/V) 92/22 μg o.d., via Ellipta